Detalles de la búsqueda
1.
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season.
J Prev Med Hyg
; 65(1): E11-E16, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706768
2.
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants.
Viruses
; 16(2)2024 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38399944
3.
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy.
Vaccines (Basel)
; 11(4)2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37112782
4.
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.
Viruses
; 14(7)2022 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35891355
5.
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination.
J Infect
; 87(3): 270-272, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37394012
Resultados
1 -
5
de 5
1
Próxima >
>>